Application 020884
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AGGRENOX | ASPIRIN; DIPYRIDAMOLE | CAPSULE, EXTENDED RELEASE;ORAL | 25MG;200MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0093-3040 | Aspirin and Dipyridamole | Aspirin and Dipyridamole | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0597-0001 | Aggrenox | aspirin and dipyridamole | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0001 | Aggrenox | aspirin and dipyridamole | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | Current |
| 0597-0001 | Aggrenox | aspirin and dipyridamole | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0001 | Aggrenox | aspirin and dipyridamole | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 21695-656 | Aggrenox | aspirin and dipyridamole | Rebel Distributors Corp. | NDA | Current |
| 68151-3971 | Aggrenox | aspirin and dipyridamole | Carilion Materials Management | NDA | Current |
| 70436-092 | aspirin and dipyridamole | aspirin and dipyridamole | Slate Run Pharmaceuticals, LLC | NDA AUTHORIZED GENERIC | Current |
| 70436-092 | aspirin and dipyridamole | aspirin and dipyridamole | Slate Run Pharmaceuticals, LLC | NDA AUTHORIZED GENERIC | Current |
| 70436-092 | aspirin and dipyridamole | aspirin and dipyridamole | Slate Run Pharmaceuticals, LLC | NDA AUTHORIZED GENERIC | Current |
| 70436-092 | aspirin and dipyridamole | aspirin and dipyridamole | Slate Run Pharmaceuticals, LLC | NDA AUTHORIZED GENERIC | Current |